Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · Real-Time Price · USD
1.560
+0.100 (6.85%)
At close: Apr 17, 2026, 4:00 PM EDT
1.565
+0.005 (0.33%)
After-hours: Apr 17, 2026, 7:27 PM EDT
Co-Diagnostics Revenue
In the year 2025, Co-Diagnostics had annual revenue of $622.49K, down -84.10%. Co-Diagnostics had revenue of $263.92K in the quarter ending December 31, 2025, with 76.74% growth.
Revenue (ttm)
$622.49K
Revenue Growth
-84.10%
P/S Ratio
9.03
Revenue / Employee
$5,413
Employees
115
Market Cap
5.62M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 622.49K | -3.29M | -84.10% |
| Dec 31, 2024 | 3.92M | -2.90M | -42.53% |
| Dec 31, 2023 | 6.81M | -27.41M | -80.09% |
| Dec 31, 2022 | 34.22M | -63.67M | -65.04% |
| Dec 31, 2021 | 97.89M | 23.33M | 31.30% |
| Dec 31, 2020 | 74.55M | 74.34M | 34,579.91% |
| Dec 31, 2019 | 214.97K | 175.06K | 438.63% |
| Dec 31, 2018 | 39.91K | 32.25K | 420.90% |
| Dec 31, 2017 | 7.66K | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | 10.00K | - | - |
| Dec 31, 2014 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| INVO Fertility | 6.94M |
| Beyond Air | 6.92M |
| Biomerica | 4.33M |
| Tenon Medical | 3.94M |
| Intelligent Bio Solutions | 3.58M |
| iTonic Holdings | 523.03K |
| Tivic Health Systems | 482.00K |
| HeartSciences | 8.67K |
CODX News
- 3 days ago - Co-Diagnostics Invited to Present at Stop TB Partnership Summit in Washington, D.C. - PRNewsWire
- 5 days ago - Co-Diagnostics to Showcase Co-Dx PCR Platform and CE-IVD Solutions at ESCMID 2026 in Munich, Germany - PRNewsWire
- 10 days ago - Co-Diagnostics Executives to Participate in European Trade Mission with Utah Governor and WTC Utah - PRNewsWire
- 19 days ago - Co-Diagnostics Reports Full Year 2025 Financial Results - PRNewsWire
- 25 days ago - Co-Diagnostics Ships Diagnostic Materials to India for Initiation of Tuberculosis Clinical Studies Following Recently Issued Guidance from the World Health Organization - PRNewsWire
- 25 days ago - EXCLUSIVE: Co-Diagnostics Ships Diagnostic Tests To India Ahead Of TB Study Launch - Benzinga
- 4 weeks ago - Co-Diagnostics Signs Agreement to Significantly Expand Commercial and Distribution Territory Across South Asia - PRNewsWire
- 4 weeks ago - EXCLUSIVE: Co-Diagnostics Expands South Asia Reach, Targets $13 Billion Market Opportunity - Benzinga